This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.Need a new registration confirmation email? Click here

Boston Scientific Inc. (BSX): Today's Featured Health Services Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Boston Scientific (
BSX) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.4%. By the end of trading, Boston Scientific rose $0.14 (1.3%) to $11.28 on average volume. Throughout the day, 13,105,950 shares of Boston Scientific exchanged hands as compared to its average daily volume of 16,187,100 shares. The stock ranged in a price between $11.12-$11.39 after having opened the day at $11.12 as compared to the previous trading day's close of $11.14. Other companies within the Health Services industry that increased today were:
Response Genetics (
RGDX), up 27.1%,
Spherix (
SPEX), up 22.4%,
Uroplasty (
UPI), up 8.0% and
ZELTIQ Aesthetics (
ZLTQ), up 7.9%.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $15.0 billion and is part of the health care sector. Shares are up 95.1% year to date as of the close of trading on Friday. Currently there are 4 analysts that rate Boston Scientific a buy, no analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates Boston Scientific as a
hold. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, solid stock price performance and expanding profit margins. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall.